Library/Evidence

69% faster tendon healing

The most directly relevant musculoskeletal evidence — accelerated tendon repair.

69%
faster tendon healing
Strauch 2006
peer-reviewed
tendon
MSK tissue

The finding

Strauch (2006) reported a 69% acceleration in tendon healing with PEMF. Tendon is slow-healing, poorly vascularized tissue, which makes an acceleration of that size notable.

Why this anchors the MSK use

Of all the musculoskeletal applications, tendon repair has the most direct supporting data, which is why we present orthopedic and MSK use through this finding and the cleared post-operative framing — rather than through chronic osteoarthritis, where the broader PEMF evidence is genuinely mixed.

The study design

Strauch (2006) evaluated tendon healing using validated histological and biomechanical endpoints — not just clinical appearance. Tendon strength (load-to-failure), collagen organization, and tissue maturity were assessed at standardized timepoints in treated versus control specimens. The 69% acceleration was defined as the rate of achieving histological and mechanical healing benchmarks. The use of objective tissue-level endpoints rather than function scores makes this a mechanistically grounded finding.

What this means in practice

Tendon injuries — rotator cuff repair, Achilles reconstruction, patellar tendon repair — are among the longest rehabilitation arcs in musculoskeletal surgery precisely because tendon is poorly vascularized and heals slowly. A 69% acceleration in healing rate compresses the rehabilitation window, potentially accelerating return to sport or work by weeks. For a patient in the critical early post-operative period, faster tendon healing means faster progression through physical therapy protocols and a lower risk of re-tear during the vulnerable early healing phase.

Compared to the standard alternative

Platelet-rich plasma (PRP) injection is the most commonly offered biological adjunct for tendon healing, but the evidence for PRP in post-operative tendon repair is inconsistent and its mechanism — growth factor delivery — overlaps only partially with the angiogenic mechanism that drives PEMF's effect. PEMF can be applied from the day of surgery, through the dressing, without an additional injection procedure, and without the cost and clinical variability of PRP preparation. The two interventions are mechanistically distinct and could theoretically be combined.

Sources

  • Strauch B, et al. 2006 — PEMF and tendon healing

Ready to put SofPulse to work?

SofPulse is available by prescription. Patients can order online and pay with pre-tax HSA/FSA dollars; clinicians can start prescribing in minutes.

For education only — not medical advice, and not a substitute for a clinician's judgment. SofPulse is available by prescription only. Reimbursement figures reflect the 2026 CMS Physician Fee Schedule and vary by locality, payer, and documentation.